Assignee
ELAN PHARM INC
US·181 granted patents·50 pending applications·4,011 citations·filing 1992–2015
Top patents by PatentIndex Score
231 records- 0198US7910333B2Antibodies to alpha-synucleinELAN PHARM INC·Filed 2010·Granted Mar 22, 2011·52 cites·9 claims
- 0298US7524812B2Pharmaceutical formulation comprising ziconotideELAN PHARM INC·Filed 2007·Granted Apr 28, 2009·92 cites·20 claims
- 0398US7049306B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.ELAN PHARM INC·Filed 2002·Granted May 23, 2006·90 cites·6 claims
- 0497US7928203B2Chimeric, humanized, or human antibody 2A4ELAN PHARM INC·Filed 2008·Granted Apr 19, 2011·38 cites·3 claims
- 0596US8349321B2Immunoglobulin formulation and method of preparation thereofELAN PHARM INC·Filed 2009·Granted Jan 8, 2013·65 cites·4 claims
- 0696US7674599B2Methods of using antibodies to detect alpha-synuclein in fluid samplesELAN PHARM INC·Filed 2004·Granted Mar 9, 2010·49 cites·11 claims
- 0796US5942400AAssays for detecting β-secretaseELAN PHARM INC·Filed 1996·Granted Aug 24, 1999·278 cites·5 claims
- 0895US7977316B2Prevention and treatment of amyloidogenic diseasesELAN PHARM INC·Filed 2007·Granted Jul 12, 2011·19 cites·20 claims
- 0995US7807167B2Administration of agents for the treatment of inflammationELAN PHARM INC·Filed 2006·Granted Oct 5, 2010·37 cites·11 claims
- 1095US7358331B2Truncated fragments of alpha-synuclein in Lewy body diseaseELAN PHARM INC·Filed 2005·Granted Apr 15, 2008·43 cites·11 claims
- 1195US7268109B2Method for reducing painELAN PHARM INC·Filed 2004·Granted Sep 11, 2007·48 cites·6 claims
- 1295US6492372B1Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Dec 10, 2002·49 cites·6 claims
- 1395US6436904B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Aug 20, 2002·39 cites·32 claims
- 1495US6407066B1Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Jun 18, 2002·52 cites·16 claims
- 1595US6407128B1Method for increasing the bioavailability of metaxaloneELAN PHARM INC·Filed 2001·Granted Jun 18, 2002·75 cites·22 claims
- 1695US6245964B1Transgenic rodent comprising APP-SwedishELAN PHARM INC·Filed 1998·Granted Jun 12, 2001·82 cites·15 claims
- 1795US6114133AMethods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41)ELAN PHARM INC·Filed 1994·Granted Sep 5, 2000·187 cites·20 claims
- 1895US6033665ACompositions and methods for modulating leukocyte adhesion to brain endothelial cellsELAN PHARM INC·Filed 1995·Granted Mar 7, 2000·141 cites·13 claims
- 1994US7919088B2Treatment and delay of onset of synucleinopathic and amyloidogenic diseaseELAN PHARM INC·Filed 2007·Granted Apr 5, 2011·40 cites·15 claims
- 2094US7427628B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2006·Granted Sep 23, 2008·23 cites·14 claims
- 2194US6683102B2Methods of using metaxalone in the treatment of musculoskeletal conditionsELAN PHARM INC·Filed 2002·Granted Jan 27, 2004·53 cites·15 claims
- 2294US6509331B1Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsELAN PHARM INC·Filed 1999·Granted Jan 21, 2003·81 cites·45 claims
- 2394US6479492B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Nov 12, 2002·41 cites·7 claims
- 2493US6982264B2Substituted alcohols useful in treatment of Alzheimer's diseaseELAN PHARM INC·Filed 2002·Granted Jan 3, 2006·38 cites·10 claims
- 2593US6794506B23-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2001·Granted Sep 21, 2004·30 cites·22 claims
- 2693US6284221B1Method for identifying β-amyloid peptide production inhibitorsELAN PHARM INC·Filed 1996·Granted Sep 4, 2001·132 cites·9 claims
- 2792US7005433B2Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2003·Granted Feb 28, 2006·27 cites·9 claims
- 2892US6627739B1β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2000·Granted Sep 30, 2003·48 cites·1 claims
- 2992US6221645B1β-secretase antibodyELAN PHARM INC·Filed 1996·Granted Apr 24, 2001·95 cites·5 claims
- 3092US6191166B1Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesisELAN PHARM INC·Filed 1997·Granted Feb 20, 2001·83 cites·31 claims
- 3191US7262043B2β-secretase enzyme compositions and methodsELAN PHARM INC·Filed 2005·Granted Aug 28, 2007·9 cites·4 claims
- 3291US6974829B2Succinoyl aminopyrazoles and related compoundsELAN PHARM INC·Filed 2003·Granted Dec 13, 2005·33 cites·8 claims
- 3390US7135477B2Heterocyclic compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Nov 14, 2006·28 cites·9 claims
- 3490US7034182B2Compounds to treat Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Apr 25, 2006·37 cites·45 claims
- 3590US6018024AMethods and compositions for monitoring cellular processing of beta-amyloid precursor proteinELAN PHARM INC·Filed 1997·Granted Jan 25, 2000·69 cites·3 claims
- 3690US5891849AMethods and formulations for preventing progression of neuropathic painELAN PHARM INC·Filed 1997·Granted Apr 6, 1999·94 cites·10 claims
- 3789US7727997B2N,N′-substituted-1,3-diamino-2-hydroxypropane derivativesELAN PHARM INC·Filed 2006·Granted Jun 1, 2010·21 cites·27 claims
- 3889US7312360B2Substituted hydroxyethylaminesELAN PHARM INC·Filed 2002·Granted Dec 25, 2007·39 cites·11 claims
- 3989US6136786AMethod for enhancing analgesiaELAN PHARM INC·Filed 1999·Granted Oct 24, 2000·52 cites·6 claims
- 4088US7223774B2Benzamide 2-hydroxy-3-diaminoalkanesELAN PHARM INC·Filed 2004·Granted May 29, 2007·34 cites·13 claims
- 4188US6689781B2Phenylalanine derivatives as alpha 4 integrin inhibitorsELAN PHARM INC·Filed 2001·Granted Feb 10, 2004·27 cites·9 claims
- 4288US6616914B2Method for pulmonary and oral delivery of pharmaceuticalsELAN PHARM INC·Filed 2001·Granted Sep 9, 2003·32 cites·23 claims
- 4388US6455557B1Method of reducing somnolence in patients treated with tizanidineELAN PHARM INC·Filed 2001·Granted Sep 24, 2002·35 cites·21 claims
- 4487US7205310B2Pyrimidine hydantoin analogues which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2005·Granted Apr 17, 2007·11 cites·19 claims
- 4587US6664442B2Selecting compounds to reduce inflammation associated with Alzheimer's diseaseELAN PHARM INC·Filed 2001·Granted Dec 16, 2003·29 cites·43 claims
- 4687US6329163B1Assays for detecting β-secretase inhibitionELAN PHARM INC·Filed 1998·Granted Dec 11, 2001·68 cites·15 claims
- 4786US7601528B1Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's diseaseELAN PHARM INC·Filed 2005·Granted Oct 13, 2009·13 cites·2 claims
- 4886US7335663B2Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrinsELAN PHARM INC·Filed 2003·Granted Feb 26, 2008·19 cites·8 claims
- 4986US6545003B1Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4ELAN PHARM INC·Filed 2000·Granted Apr 8, 2003·23 cites·7 claims
- 5086US6451828B1Selective inhibition of glutaminase by bis-thiadiazolesELAN PHARM INC·Filed 2001·Granted Sep 17, 2002·30 cites·15 claims
Showing the top 50 of 231 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →